Lateral flow assay as radiological prognosis factor of pulmonary cryptococcosis: a single center retrospective study in China

Jiejun Shi, Jianhua Chen, Qianjiang Ding, Guoqing Qian, Zeqin Zhang, Qifa SongFrontiers in Cellular and Infection Microbiology 2025 · DOI

TL;DR

This study investigates the utility of a lateral flow assay (LFA) for predicting the radiological outcomes of pulmonary cryptococcosis (PC) in HIV-negative patients. The findings suggest that LFA, both at baseline and after treatment, can serve as a valuable prognostic tool, potentially guiding clinical management and treatment adjustments.

What Problem Does This Paper Address?

Pulmonary cryptococcosis (PC) is a significant opportunistic infection, particularly concerning in immunocompetent individuals where it can be underdiagnosed and challenging to assess treatment efficacy. Current diagnostic tools for PC are often limited in their ability to predict how well patients will respond to therapy, especially in terms of radiological improvement. While lateral flow assays (LFAs) are known for their sensitivity and specificity in diagnosing cryptococcosis, their role in monitoring therapeutic response and predicting radiological outcomes in PC has remained underexplored. This paper aims to fill this gap by examining whether LFA results can serve as a reliable indicator of radiological prognosis in HIV-negative patients with PC.

Methods

This study employed a retrospective analysis of 168 HIV-negative patients diagnosed with pulmonary cryptococcosis. The core of the methodology involved:

  • Lateral Flow Assay (LFA): Serum samples were tested using an LFA kit to detect cryptococcal antigen. Results were categorized as negative, weak positive, or positive. "Baseline LFA" referred to tests conducted within a week of diagnosis, and "post-treatment LFA" were those taken 5-7 months after initiating antifungal therapy. Changes in LFA were categorized as "decreased" or "equal or increased."
  • Radiological Examinations: Chest CT scans were performed at least twice during treatment. Radiologists independently reviewed these scans to assess the radiological outcome, categorizing it as aggravated, unchanged, partial absorption, or complete absorption. Lesion extent was also categorized (single pulmonary lobe, unilateral lung, bilateral lungs).
  • Statistical Analysis: A range of statistical methods were used to analyze the data, including:
  • Gamma test and trend chi-square test: To assess the correlation and trends between ordered categorical variables like baseline LFA, changes in LFA, and radiological outcomes.
  • Ordinal logistic regression: To evaluate the association between LFA and radiological prognosis, providing odds ratios (ORs) for improved imaging outcomes.
  • Student's t-test and Mann-Whitney U test: For comparing continuous variables.
  • Chi-squared test: For comparing categorical variables.

Datasets

The study utilized data from the YIDUCLOUD platform of the First Affiliated Hospital of Ningbo University, encompassing patient records from January 2010 to January 2024. No new benchmarks were introduced; the study relied on existing patient data.

Key Insights and Ideas

  • LFA as a Prognostic Indicator: The study strongly suggests that LFA is not just a diagnostic tool but also a valuable predictor of how well pulmonary lesions will resolve radiologically.
  • Baseline LFA Matters: A higher baseline LFA grade was associated with a worse radiological prognosis, indicating that patients with a stronger initial antigen signal may face more challenges in lesion resorption.
  • Change in LFA is Crucial: A decrease in LFA after antifungal therapy was significantly linked to better radiological outcomes, highlighting the importance of monitoring LFA trends during treatment.
  • Lesion Distribution as a Factor: While not as consistently significant as LFA, lesions confined to the right lung showed a tendency towards more favorable radiological outcomes, potentially due to anatomical differences.
  • HIV-Negative Focus: The study specifically focuses on HIV-negative individuals, providing insights into PC management in a population that might have different clinical trajectories compared to HIV-positive patients.

Key Results

  • Remission Rate: 84.5% of the 168 participants experienced partial or complete absorption of pulmonary lesions.
  • Baseline LFA and Prognosis: A significant negative association was found between baseline LFA grade and radiological outcome (Gamma γ = -0.368, P = 0.045), meaning higher baseline LFA was linked to worse prognosis.
  • LFA Change and Prognosis: Patients with a decrease in LFA after treatment showed significantly better radiological outcomes compared to those with equal or increased LFA (Gamma γ = 0.371, P = 0.012).
  • Ordinal Logistic Regression: Patients with decreased LFA after treatment had a higher probability of improved radiological outcomes (OR = 2.324, P = 0.016). Negative or weak positive baseline LFA also correlated with better outcomes (OR = 6.895, P = 0.006 for LFA-negative; OR = 1.565, P = 0.006 for weak positive LFA).
  • Lesion Distribution: Lesions restricted to the right lung were more likely to have favorable radiological outcomes compared to those in the left lung or bilateral lungs (P < 0.05).

Limitations and Future Work

  • Qualitative LFA: The study acknowledges a major limitation is the use of a qualitative LFA test, rather than a quantitative one. Future research could benefit from comparing antigen titers to establish predictive curves.
  • Small Sample Size (LFA-Negative Group): The LFA-negative group was small, which may have introduced statistical bias and reduced the reliability of findings related to this subgroup.
  • Single-Center Study: The retrospective nature and single-center design limit the generalizability of the findings.
  • Future Directions: The authors suggest a large-scale, multi-center study is needed to validate these findings. Further research could also explore the quantitative aspect of LFA and its correlation with clinical outcomes.

Summary updated

Abstract

LFA shows potential of monitoring radiological outcomes in pulmonary cryptococcosis.
BibTeX
@inproceedings{shi2025lateral,
  author = {Jiejun Shi and Jianhua Chen and Qianjiang Ding and Guoqing Qian and Zeqin Zhang and Qifa Song},
  title = {{Lateral flow assay as radiological prognosis factor of pulmonary cryptococcosis: a single center retrospective study in China}},
  booktitle = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2024.1497082},
}
Figure